ShilpaKodatiMD
Ophthalmology • Ann Arbor, MIRetinal Disease, Uveitis
Vitreoretinal Surgeon and Uveitis specialist
Dr. Kodati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190
Summary
- Dr. Shilpa Kodati is an ophthalmologist in Bethesda, MD. She specializes in vitreoretinal surgery and uveitis and is experienced in uveitis, retina surgery, immunology, vitreoretinal disease, and retinal imaging.
Education & Training
Baylor College of MedicineFellowship, Surgical Retina and Vitreous, 2017 - 2019
National Institutes of Health Clinical CenterFellowship, Ocular Immunology/Uveitis, 2016 - 2017
UPMC Medical EducationResidency, Ophthalmology, 2013 - 2016
MetroWest Medical CenterInternship, Transitional Year, 2012 - 2013
Imperial College London School of MedicineClass of 2008
Certifications & Licensure
TX State Medical License 2017 - 2026
MI State Medical License 2022 - 2025
DC State Medical License 2020 - 2024
PA State Medical License 2013 - 2024- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 6 citationsOcular symptoms in COVID-19 infection: a survey study.Matthew McHarg, Yujuan Wang, Mehmet Yakin, Alex Zeleny, Sonny Caplash
Journal of Ophthalmic Inflammation and Infection. 2022-12-20 - 51 citationsBilateral posterior uveitis associated with Zika virus infectionShilpa Kodati, Tara N. Palmore, Frank A Spellman, Denise Cunningham, Benjamin Weistrop
Lancet. 2017-01-07 - 69 citationsKinetics and function of mesenchymal stem cells in corneal injury.Yinan Lan, Shilpa Kodati, Hyun Soo Lee, Masahiro Omoto, Yiping Jin
Investigative Ophthalmology & Visual Science. 2012-06-14
Press Mentions
First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMDSeptember 2nd, 2022- First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMDSeptember 1st, 2022
- ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship RecipientJanuary 21st, 2021
Professional Memberships
- Member
- Member
- American Uveitis SocietyMember
- The Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
